AllianceBernstein reports 0.1% stake in Cross Country

AllianceBernstein L.P. filed Amendment No. 2 to a Schedule 13G/A reporting its beneficial ownership of Cross Country Healthcare Inc. common stock.

Accepted by SEC EDGAR 02/17/2026 - 05:06 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

AllianceBernstein L.P. filed Amendment No. 2 to a Schedule 13G/A reporting its beneficial ownership of Cross Country Healthcare Inc. common stock. As of 12/31/2025, AllianceBernstein reported beneficial ownership of 31,215 shares, representing 0.1% of the outstanding common stock.

The shares are held solely for investment purposes in client discretionary investment advisory accounts, with AllianceBernstein having sole voting and dispositive power over these shares and no shared power. The filing states the holdings are in the ordinary course of business and not for changing or influencing control of Cross Country Healthcare.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does AllianceBernstein’s Schedule 13G/A filing reveal about CCRN?

AllianceBernstein L.P. reports beneficial ownership of 31,215 Cross Country Healthcare common shares, equal to 0.1% of the class as of December 31, 2025. The position is held for investment in client advisory accounts, not to influence control of the company.

How many Cross Country Healthcare (CCRN) shares does AllianceBernstein own?

AllianceBernstein L.P. reports beneficial ownership of 31,215 Cross Country Healthcare common shares. These shares are held in discretionary investment advisory accounts for clients, with AllianceBernstein having sole voting and sole dispositive power over the reported shares, representing 0.1% of the class.

What percentage of Cross Country Healthcare’s stock is held by AllianceBernstein?

AllianceBernstein L.P. states it beneficially owns 0.1% of Cross Country Healthcare’s common stock. This percentage reflects 31,215 shares held in client investment advisory accounts, with AllianceBernstein exercising sole voting and dispositive authority over those shares as of December 31, 2025.

Is AllianceBernstein seeking to influence control of Cross Country Healthcare (CCRN)?

AllianceBernstein certifies the CCRN shares were acquired and are held in the ordinary course of business. The filing states they were not acquired and are not held for the purpose or effect of changing or influencing control of Cross Country Healthcare or as part of such a transaction.

In what capacity does AllianceBernstein hold CCRN shares reported on this Schedule 13G/A?

AllianceBernstein holds the 31,215 Cross Country Healthcare shares on behalf of client discretionary investment advisory accounts. AllianceBernstein has sole power to vote and dispose of these shares and reports ownership of 5 percent or less of the class, consistent with a passive investment role.

Who signed the Schedule 13G/A for AllianceBernstein regarding CCRN?

The Schedule 13G/A was signed by Marcus Edwards, AVP/ Senior Compliance Associate at AllianceBernstein L.P., dated February 17, 2026. The signature certifies, after reasonable inquiry, that the information in the statement is true, complete, and correct to the best of his knowledge and belief.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

Cross Country Healthcare Inc

(Name of Issuer)

Common Stock

(Title of Class of Securities)

227483104

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 227483104

1

Names of Reporting Persons

AllianceBernstein L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 31,215.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 31,215.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

31,215.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.1 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Cross Country Healthcare Inc
(b)	Address of issuer's principal executive offices: 5201 CONGRESS AVENUE, SUITE 160,, BOCA RATON, FL 33487
Item 2.
(a)	Name of person filing: AllianceBernstein L.P. ("AllianceBernstein L.P.")
(b)	Address or principal business office or, if none, residence: 501 Commerce Street, Nashville, TN 37203 All media outlets, please contact Jennifer Will at AllianceBernstein (212-969-1157) with any questions. All other questions can be directed to Section13USFilings@alliancebernstein.com.
(c)	Citizenship: Delaware
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 227483104
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 31,215 shares acquired solely for investment purposes on behalf of client discretionary investment advisory accounts.* *AllianceBernstein L.P. is a majority owned subsidiary of Equitable Holdings, Inc. ("EQH"). AllianceBernstein operates under independent management and makes independent decisions from EQH and its respective subsidiaries, and EQH calculates and reports beneficial ownership separately from AllianceBernstein pursuant to guidance provided by the Securities and Exchange Commission in Release Number 34-39538 (January 12, 1998).
(b)	Percent of class: 0.1 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 31,215
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 31,215
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

AllianceBernstein L.P.

Signature:	Marcus Edwards
Name/Title:	AVP/ Senior Compliance Associate
Date:	02/17/2026